News
The following is a summary of “Twice against thrice-weekly hemodialysis (TATH): a multicenter nonrandomized trial,” published ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback